Literature DB >> 734382

Release of lysosomal enzymes from human polymorphonuclear leukocytes by soluble intermediate immune complexes.

A D Morrison, W Pruzanski, N S Ranadive.   

Abstract

The efficacy of soluble immune complexes (1C) of different sizes prepared in vitro or present in RA sera and synovial fluids to induce the release of beta-glucuronidase (BG) and neutral protease (NP) from PMN has been examined. Immune complexes of human HGG-rabbit anti-human HGG prepared in 5, 10 and 20 times excess of antigen equivalence were fractionated into three pools, PI (22S--13S), PII (13S--7S) and PIII (7S) using Sephadex G-200 column chromatography. NP and BG-releasing activity was mostly associated with PII. Similar fractions were obtained from RA sera and synovial fluids. BG-releasing activity was again predominantly associated with PII. PII fractions from normal sera and from 2 non-RA IC disease sera showed less BG-releasing activity than the RA PII fractions. Negligible NP release was observed with all three serum pools. Further investigation demonstrated the presence of NP inhibitor(s) in PI and PII from human sera.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 734382     DOI: 10.3109/03009747809095663

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  9 in total

1.  The expression of Fc receptors on guinea-pig peritoneal macrophages and neutrophils.

Authors:  K Coupland; R G Leslie
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

2.  Generation of superoxide by immunologically stimulated normal human neutrophils and possible modulation by intracellular and extracellular SOD and rheumatoid factors.

Authors:  M Shingu; T Todoroki; M Nobunaga
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

3.  Depressed degranulation response of synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis to IgG aggregates.

Authors:  B Dularay; P A Dieppe; C J Elson
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

4.  Rheumatoid factor modulation of neutrophil superoxide generation enhancing activity of preformed immune complexes.

Authors:  S Oishi; M Shingu; I Ezaki; M Nobunaga; K Sakai
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

5.  Interaction of circulating immune complexes with granulocyte function in patients with rheumatoid arthritis.

Authors:  B Bültmann; R Geitner; H Seibold; G Kratsch; O Haferkamp
Journal:  Klin Wochenschr       Date:  1980-07-15

6.  The stimulation of superoxide anion production in guinea-pig peritoneal macrophages and neutrophils by phorbol myristate acetate, opsonized zymosan and IgG2-containing soluble immune complexes.

Authors:  M A Baxter; R G Leslie; W G Reeves
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

7.  Activation of neutrophil reactive-oxidant production by synovial fluid from patients with inflammatory joint disease. Soluble and insoluble immunoglobulin aggregates activate different pathways in primed and unprimed cells.

Authors:  J Robinson; F Watson; R C Bucknall; S W Edwards
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

8.  Identification of a myeloperoxidase inhibitor from normal human serum.

Authors:  C M Yea; B Dularay; C J Elson
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

9.  Immune complex-degradation ability of macrophages in MRL/Mp-lpr/lpr lupus mice and its regulation by cytokines.

Authors:  H Kanno; O Tachiwaki; M Nose; M Kyogoku
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.